
The Pharmaceutical Out-licensing Course
With David Scott
Course Details
THE CONTENT
Out-licensing an R&D compound is a critical and highly challenging process in the biopharma industry, with significant strategic and financial implications. Success depends on thorough preparation and strategic planning well before engaging with potential partners. Early missteps can jeopardise your chances of securing the right deal.
This course equips you with a clear framework and proven best practices to effectively prepare for and manage the out-licensing process from opportunity assessment and partner identification to negotiations and contract finalisation.
If you want to position your assets for success and avoid costly missteps in the out-licensing process, this course is an essential investment!
THE EXPERT
David Scott is a recognised authority in pharmaceutical business development and licensing.
Formerly a senior BD&L executive in pharma, David has worked as a Senior BD&L Consultant since 1996.
He has successfully concluded numerous inward and outward licensing agreements for clients across small molecules, biologics, and delivery technologies.
Author of Scrip’s best-selling report "Practical Guide to Pharmaceutical Licensing".
With decades of experience running successful training courses and workshops, David is known for his no-nonsense, hands-on teaching style that delivers actionable insights.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for professionals involved or soon to be involved in the out-licensing of development products, including:
Senior executives and scientists in companies developing or preparing to develop assets for out-licensing.
Junior to mid-level managers – including scientists, commercial, and legal managers – who are likely to be involved in licensing and due diligence activities.
Business development managers, legal and IP professionals, and team members new to licensing or transitioning into business development roles.
Managers seeking to broaden their career skills by gaining a solid understanding of the out-licensing process.
The interactive learning format ensures a highly engaging experience. You will have the opportunity to ask your specific questions directly to David Scott and take part in in-depth discussions, while also exchanging insights with an international group of peers who face similar challenges. This combination of expert guidance and peer-to-peer learning will give you both the knowledge and the confidence to successfully navigate the out-licensing process.
Critical initial planning decisions, such as timing and deal type.
Templates and dos & don’ts of critical documents, such as CDAs, MTAs and term sheets.
How to set up a spreadsheet to simulate the value and determine the optimal commercial structure of the deal.
How to maximise your attractiveness to potential licensing partners.
How to target licensees who are more likely to pay a premium.
Understand the due diligence process and what will be expected of you.
| Welcome & General Introduction (~15 min) |
|
| Preparing the Ground: Strategy & Planning (~45 min) |
|
| Deciding What Type of Deal to Seek (~45 min) |
|
| The Legal Agreements You Will Encounter in a Licensing Deal: Templates - Points of Caution - Do’s & don’ts (~1 h 45 min) |
|
| Lunch Break |
| Valuing the Deal With the rNPV model (~45 min) |
|
| Preparing to Out-license: The Action Plan - The Team (~30 min) |
|
| How to Prepare the Out-licensing Marketing Material (~45 min) |
|
| Preparing a Target Term Sheet (~30 min) |
|
| Finding and Attracting the Right Partners (~45 min) |
|
UPCOMING DATES & FORMATS - FEES
12 November 2026
Live online
Early bird € 1 570
(until 09/10/2026)
(Full fee € 1 770)
TIMING & LOCATION
Live Online: Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
SPECIAL OFFER FOR BIOTECH EXECUTIVES
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan for more details.
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
You will receive a digital copy of the checklists, templates and valuation tool used in this course so you can immediately use them when back in the office
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
9,0/10!
Testimonials from past participants:
I really enjoyed this out-licensing course! The instructor’s clear explanation of the different types of agreements made it a good first introduction to the topic. Highly recommended for building a foundational understanding.
Laboratórios Azevedos
Inês Vaz Ribeiro, International Business Development | Out Licensing - Portugal - November 2025
Interesting, light and insightful.
Antibiotice
Silviu Ionesi, Project Manager Out-Licensing - Romania - November 2025
Course Details
Dates & Locations
Upcoming Session
12 November 2026, Live online
Early bird € 1 570
(until 09/10/2026)
(Full fee € 1 770)
Prices are excl. VAT
THE CONTENT
Out-licensing an R&D compound is a critical and highly challenging process in the biopharma industry, with significant strategic and financial implications. Success depends on thorough preparation and strategic planning well before engaging with potential partners. Early missteps can jeopardise your chances of securing the right deal.
This course equips you with a clear framework and proven best practices to effectively prepare for and manage the out-licensing process from opportunity assessment and partner identification to negotiations and contract finalisation.
If you want to position your assets for success and avoid costly missteps in the out-licensing process, this course is an essential investment!
THE EXPERT
David Scott is a recognised authority in pharmaceutical business development and licensing.
Formerly a senior BD&L executive in pharma, David has worked as a Senior BD&L Consultant since 1996.
He has successfully concluded numerous inward and outward licensing agreements for clients across small molecules, biologics, and delivery technologies.
Author of Scrip’s best-selling report "Practical Guide to Pharmaceutical Licensing".
With decades of experience running successful training courses and workshops, David is known for his no-nonsense, hands-on teaching style that delivers actionable insights.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for professionals involved or soon to be involved in the out-licensing of development products, including:
Senior executives and scientists in companies developing or preparing to develop assets for out-licensing.
Junior to mid-level managers – including scientists, commercial, and legal managers – who are likely to be involved in licensing and due diligence activities.
Business development managers, legal and IP professionals, and team members new to licensing or transitioning into business development roles.
Managers seeking to broaden their career skills by gaining a solid understanding of the out-licensing process.
The interactive learning format ensures a highly engaging experience. You will have the opportunity to ask your specific questions directly to David Scott and take part in in-depth discussions, while also exchanging insights with an international group of peers who face similar challenges. This combination of expert guidance and peer-to-peer learning will give you both the knowledge and the confidence to successfully navigate the out-licensing process.
Critical initial planning decisions, such as timing and deal type.
Templates and dos & don’ts of critical documents, such as CDAs, MTAs and term sheets.
How to set up a spreadsheet to simulate the value and determine the optimal commercial structure of the deal.
How to maximise your attractiveness to potential licensing partners.
How to target licensees who are more likely to pay a premium.
Understand the due diligence process and what will be expected of you.
| Welcome & General Introduction (~15 min) |
|
| Preparing the Ground: Strategy & Planning (~45 min) |
|
| Deciding What Type of Deal to Seek (~45 min) |
|
| The Legal Agreements You Will Encounter in a Licensing Deal: Templates - Points of Caution - Do’s & don’ts (~1 h 45 min) |
|
| Lunch Break |
| Valuing the Deal With the rNPV model (~45 min) |
|
| Preparing to Out-license: The Action Plan - The Team (~30 min) |
|
| How to Prepare the Out-licensing Marketing Material (~45 min) |
|
| Preparing a Target Term Sheet (~30 min) |
|
| Finding and Attracting the Right Partners (~45 min) |
|
UPCOMING DATES & FORMATS - FEES
12 November 2026
Live online
Early bird € 1 570
(until 09/10/2026)
(Full fee € 1 770)
TIMING & LOCATION
Live Online: Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
SPECIAL OFFER FOR BIOTECH EXECUTIVES
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan for more details.
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
You will receive a digital copy of the checklists, templates and valuation tool used in this course so you can immediately use them when back in the office
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
9,0/10!
Testimonials from past participants:
I really enjoyed this out-licensing course! The instructor’s clear explanation of the different types of agreements made it a good first introduction to the topic. Highly recommended for building a foundational understanding.
Laboratórios Azevedos
Inês Vaz Ribeiro, International Business Development | Out Licensing - Portugal - November 2025
Interesting, light and insightful.
Antibiotice
Silviu Ionesi, Project Manager Out-Licensing - Romania - November 2025




